Target intelligence / Profile preview

Voltage-gated sodium channel NaChBac (NaChBac)

Target
NaChBac
Molecular classification
Ion channel, Voltage-gated ion channel, Voltage-gated sodium channel, 6TM ion channel
01

Overview

NaChBac (Sodium Channel of Bacillus halodurans) is a prokaryotic voltage-gated sodium channel that serves as a foundational structural and functional model for eukaryotic voltage-gated sodium (Nav) and calcium (Cav) channels [2, 3]. Identified in the alkaliphilic bacterium Bacillus halodurans, it is a homotetramer composed of four identical subunits, each containing six transmembrane segments, which is a simpler architecture compared to the four-domain pseudo-tetrameric structure of human Nav channels [4, 10]. NaChBac demonstrates voltage-dependent activation and high selectivity for sodium ions, though its activation and inactivation kinetics are approximately 10 to 100 times slower than its mammalian counterparts [4, 9]. It is extensively utilized in pharmacological research to investigate the molecular basis of ion selectivity and the binding sites of drugs such as local anesthetics, antiarrhythmics, and calcium channel blockers [5, 7, 15]. Although it is not a direct therapeutic target for human diseases, it is a vital surrogate for studying channelopathies like epilepsy and cardiac arrhythmias [11, 15]. Furthermore, it serves as a tool in optogenetics and chemogenetics for modulating membrane potential in heterologous systems like neurons [12]. The channel's sensitivity to various toxins and small molecules makes it an ideal platform for high-throughput screening and structural biology studies [13, 15].

Other names
Sodium channel of Bacillus haloduransBacterial voltage-gated sodium channelNavBhSodium channel protein NaChBac
02

Mechanism of action

Inhibition of sodium ion conductance through pore blockade, stabilization of the inactivated state, or impedance of voltage-sensor activation [1, 5, 13].

03

Biological functions

Sodium ion transportVoltage-dependent gatingElectrical signalingChemotaxisMotilityNeuron activation
04

Disease associations

EpilepsyCardiac arrhythmiaChronic painChannelopathyLong QT syndrome
05

Safety considerations

Structural divergence from human Nav channelsSignificantly slower gating kineticsPotential for poor translatability of drug-target interactions to eukaryotic systems
06

Interacting drugs

Propofol

11 more in the full profile.

Beyond the preview

Go deeper on Voltage-gated sodium channel NaChBac (NaChBac).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Voltage-gated sodium channel NaChBac (NaChBac).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call